Genetic Biomarkers of Metabolic Detoxification for Personalized Lifestyle Medicine.

LIFEHOUSE study biomarkers biotransformation detoxification environmental health functional medicine nutrigenomics personalized lifestyle medicine pragmatic clinical trials single nucleotide polymorphisms

Journal

Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595

Informations de publication

Date de publication:
11 Feb 2022
Historique:
received: 18 01 2022
revised: 07 02 2022
accepted: 08 02 2022
entrez: 26 2 2022
pubmed: 27 2 2022
medline: 3 3 2022
Statut: epublish

Résumé

Metabolic detoxification (detox)-or biotransformation-is a physiological function that removes toxic substances from our body. Genetic variability and dietary factors may affect the function of detox enzymes, thus impacting the body's sensitivity to toxic substances of endogenous and exogenous origin. From a genetic perspective, most of the current knowledge relies on observational studies in humans or experimental models in vivo and in vitro, with very limited proof of causality and clinical value. This review provides health practitioners with a list of single nucleotide polymorphisms (SNPs) located within genes involved in Phase I and Phase II detoxification reactions, for which evidence of clinical utility does exist. We have selected these SNPs based on their association with interindividual variability of detox metabolism in response to certain nutrients in the context of human clinical trials. In order to facilitate clinical interpretation and usage of these SNPs, we provide, for each of them, a strength of evidence score based on recent guidelines for genotype-based dietary advice. We also present the association of these SNPs with functional biomarkers of detox metabolism in a pragmatic clinical trial, the LIFEHOUSE study.

Identifiants

pubmed: 35215417
pii: nu14040768
doi: 10.3390/nu14040768
pmc: PMC8876337
pii:
doi:

Substances chimiques

Genetic Markers 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Références

Free Radic Res. 2009 Jun;43(6):533-7
pubmed: 19370474
J Natl Cancer Inst. 1996 May 1;88(9):617
pubmed: 8609664
Int J Mol Sci. 2020 Oct 18;21(20):
pubmed: 33080955
Carcinogenesis. 2007 Aug;28(8):1800-6
pubmed: 17602170
Am J Epidemiol. 2008 Apr 1;167(7):759-74
pubmed: 18270371
J Nutr. 2004 May;134(5):1134-8
pubmed: 15113959
Int J Cancer. 2009 Dec 1;125(11):2652-9
pubmed: 19610060
Cancer Epidemiol Biomarkers Prev. 2000 Aug;9(8):787-93
pubmed: 10952095
Arh Hig Rada Toksikol. 2009 Jun;60(2):217-42
pubmed: 19581216
Br J Nutr. 2011 Apr;105(8):1138-44
pubmed: 21144097
J Epidemiol Community Health. 2009 Nov;63(11):884-6
pubmed: 19825792
Rev Environ Health. 2013;28(1):59-65
pubmed: 23612529
Lancet. 2000 Aug 26;356(9231):724-9
pubmed: 11085692
J Biochem. 1999 Apr;125(4):803-8
pubmed: 10101295
Genet Med. 2009 Jan;11(1):21-34
pubmed: 19125129
Genes Nutr. 2017 Dec 15;12:35
pubmed: 29270237
Cancer Epidemiol Biomarkers Prev. 2009 Nov;18(11):3118-25
pubmed: 19843669
Cancer Prev Res (Phila). 2016 Jul;9(7):598-606
pubmed: 27099270
Cancer Causes Control. 2004 Dec;15(10):977-85
pubmed: 15801482
Br J Clin Pharmacol. 1999 Apr;47(4):445-9
pubmed: 10233211
Lancet. 2005 Oct 29-Nov 4;366(9496):1558-60
pubmed: 16257343
Am J Epidemiol. 2007 Jan 15;165(2):115-25
pubmed: 17053044
J Hum Nutr Diet. 2017 Apr;30(2):166-176
pubmed: 27600055
Pharmacotherapy. 2008 Jun;28(6):755-68
pubmed: 18503403
Pharmacogenetics. 1995 Oct;5(5):259-74
pubmed: 8563766
J Nutr. 2014 Nov;144(11):1850-7
pubmed: 25165394
Semin Nephrol. 2006 Jan;26(1):20-3
pubmed: 16412820
Int J Food Sci Nutr. 2009;60 Suppl 1:56-71
pubmed: 19424928
J Environ Public Health. 2012;2012:472751
pubmed: 22523504
Genes Nutr. 2007 Oct;2(1):155-6
pubmed: 18850169
Cancer Lett. 2004 Oct 28;214(2):189-95
pubmed: 15363545
J Clin Psychopharmacol. 1991 Jun;11(3):175-84
pubmed: 1820757
Cancer Res. 2000 Feb 15;60(4):950-6
pubmed: 10706110
N Engl J Med. 1995 Nov 2;333(18):1171-5
pubmed: 7565971
Amino Acids. 2003 Dec;25(3-4):409-17
pubmed: 14661100
Eur J Pharmacol. 2014 Oct 5;740:645-51
pubmed: 24972245
Int J Colorectal Dis. 2008 Aug;23(8):773-82
pubmed: 18443805
Am J Clin Nutr. 2017 Jun;105(6):1297-1304
pubmed: 28446500
Int J Mol Epidemiol Genet. 2010;1(2):114-123
pubmed: 21191472
Am J Clin Nutr. 2005 Dec;82(6):1283-91
pubmed: 16332662
Environ Res. 2017 Apr;154:325-333
pubmed: 28157646
Pharmacogenomics J. 2004;4(1):49-53
pubmed: 14647407
Am J Hum Genet. 2004 Nov;75(5):807-21
pubmed: 15457404
JAMA. 2006 Mar 8;295(10):1135-41
pubmed: 16522833
J Pers Med. 2022 Jan 15;12(1):
pubmed: 35055430
Basic Clin Pharmacol Toxicol. 2013 Apr;112(4):257-63
pubmed: 23167834
Cancer Epidemiol Biomarkers Prev. 2009 Nov;18(11):2974-8
pubmed: 19900941
Curr Drug Metab. 2002 Dec;3(6):561-97
pubmed: 12369887
Sci Rep. 2018 Feb 15;8(1):3075
pubmed: 29449662
Carcinogenesis. 2004 Jun;25(6):923-9
pubmed: 14976127
J Hypertens. 2009 Aug;27(8):1594-601
pubmed: 19451835
Hum Mol Genet. 2009 Jan 15;18(2):366-72
pubmed: 18948376
Cancer Prev Res (Phila). 2009 Apr;2(4):345-52
pubmed: 19336732
Pharmacogenomics. 2009 May;10(5):769-78
pubmed: 19450128
Mol Nutr Food Res. 2012 Jun;56(6):966-75
pubmed: 22707271
Eur J Clin Pharmacol. 2007 Jun;63(6):537-46
pubmed: 17370067
Clin Cancer Res. 2007 Dec 1;13(23):7207-16
pubmed: 18056202
Eur J Cancer. 2007 Jan;43(2):283-90
pubmed: 17084623
J Nutr. 2009 Mar;139(3):555-60
pubmed: 19141701
Biochem Pharmacol. 2002 Aug 1;64(3):393-404
pubmed: 12147290
Br J Nutr. 2011 Dec;106(12):1880-9
pubmed: 21736785
Nutr Cancer. 2004;50(2):206-13
pubmed: 15623468
J Nutr. 2007 Apr;137(4):904-9
pubmed: 17374652
Eur J Clin Pharmacol. 2010 Jul;66(7):697-703
pubmed: 20390257
Clin Exp Pharmacol Physiol. 2009 Aug;36(8):828-33
pubmed: 19215233
Cancer Res. 1998 Nov 15;58(22):5038-41
pubmed: 9823305
J Clin Biochem Nutr. 2015 Jan;56(1):49-56
pubmed: 25678751
J Pharm Pharmacol. 1985 Jan;37(1):1-12
pubmed: 2858520
Curr Atheroscler Rep. 2017 Sep 18;19(11):42
pubmed: 28921056
Carcinogenesis. 2004 May;25(5):735-40
pubmed: 14688020

Auteurs

Lucia Aronica (L)

Department of Nutrition Science, Metagenics, Inc., Aliso Viejo, CA 92656, USA.
Stanford Prevention Research Center, Department of Medicine, Stanford University, California, CA 94305, USA.

Jose M Ordovas (JM)

Nutrition and Genomics Laboratory, Jean Mayer USDA Human Nutrition Center on Aging, Tufts University, Boston, MA 02111, USA.
Nutritional Genomics and Epigenomics Group, IMDEA-Food, 28049 Madrid, Spain.
University Camilo José Cela, Villafranca del Castillo, 28692 Madrid, Spain.

Andrey Volkov (A)

Bennet Data Sciences, San Diego, CA 92107, USA.

Joseph J Lamb (JJ)

Personalized Lifestyle Medicine Center, Gig Harbor, WA 98332, USA.

Peter Michael Stone (PM)

Personalized Lifestyle Medicine Center, Gig Harbor, WA 98332, USA.
Institute for Functional Medicine Federal Way, Washington, DC 98003, USA.
Ashland Comprehensive Family Medicine-Stone Medical, Ashland, OR 97520, USA.
Office of Personalized Health and Well-Being, Medical College of Georgia, AU/UGA Medical Partnership, Athens, GA 30606, USA.

Deanna Minich (D)

Institute for Functional Medicine Federal Way, Washington, DC 98003, USA.
Human Nutrition and Functional Medicine, University of Western States, Portland, OR 97213, USA.

Michelle Leary (M)

Vida Integrated Health, Seattle, WA 98112, USA.

Monique Class (M)

Institute for Functional Medicine Federal Way, Washington, DC 98003, USA.
The Center for Functional Medicine, Stamford, CT 06905, USA.

Dina Metti (D)

Personalized Lifestyle Medicine Center, Gig Harbor, WA 98332, USA.

Ilona A Larson (IA)

Department of Nutrition Science, Metagenics, Inc., Aliso Viejo, CA 92656, USA.

Nikhat Contractor (N)

Nutrilite Health Institute, Buena Park, CA 90621, USA.

Brent Eck (B)

Department of Nutrition Science, Metagenics, Inc., Aliso Viejo, CA 92656, USA.

Jeffrey S Bland (JS)

Personalized Lifestyle Medicine Institute, Bainbridge Island, WA 98110, USA.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH